Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis
Provectus Pharmaceuticals Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis
KNOXVILLE, Tenn.–(BUSINESS WIRE)–Provectus Pharmaceuticals has completed patient accrual in its Phase 2C clinical trial of PH-10 for psoriasis.
Read more on Business Wire
Categories: Breast Cancer Information Tags: Accrual, Clinical, Completes, patient, PH10, Pharmaceuticals, Phase, Provectus, Psoriasis, Trial
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
Tigris Pharmaceuticals, Inc. Completes $6.5 Million Private Placement
Tigris Pharmaceuticals, Inc., a privately held drug development company, announced today that it has completed a private placement of Series C Convertible Preferred Stock resulting in gross proceeds of approximately $6.5 million. Â The financing, which was led by Mr.
Read more on PR Newswire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: $6.5, Completes, Inc., million, Pharmaceuticals, Placement, private, Tigris
Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer
Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.
Read more on News-Medical-Net
Categories: Breast Cancer In Men Tags: cancer, cohort, Completes, enrollment, first, liver, Phase, Provectus, PV10, Trial
Hologic Completes Acquisition of Sentinelle Medical
Hologic Completes Acquisition of Sentinelle Medical
Hologic, Inc. , a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the completion of its acquisition of Sentinelle Medical Inc. , a leading provider of Magnetic Resonance Imaging breast coils, tables and visualization software.
Read more on PR Newswire via Yahoo! Finance
Categories: High Risk Breast Cancer Tags: Acquisition, Completes, Hologic, Medical, Sentinelle
Guthrie scholar completes program
Guthrie scholar completes program
Morning Times SAYRE — Maryana Yevtukh, senior pre-med major at Wilkes University in Wilkes-Barre, Pa., recently completed the Guthrie Scholars Program.
Read more on Morning Times
Categories: Breast Cancer Information Tags: Completes, Guthrie, program, Scholar